支气管肺发育不良与解脲脲原体的关系的研究进展
Research Progress on the Relationship between Bronchopulmonary Dysplasia and Ureaplasma urealyticum
DOI: 10.12677/ACM.2024.141024, PDF,   
作者: 赵文豪:重庆医科大学附属儿童医院新生儿科,重庆;李 芳*:重庆医科大学附属妇女儿童医院儿科,重庆
关键词: 支气管肺发育不良解脲脲原体炎症反应阿奇霉素Bronchopulmonary Dysplasia Ureaplasma urealyticum Inflammation Azithromycin
摘要: 支气管肺发育不良(bronchopulmonary dysplasia, BPD)是一种以肺泡简单化、肺微血管发育障碍,伴随肺间质纤维化、肺不张及囊性变为病理特征的早产儿常见慢性肺部疾病。随着早产儿存活率的提高,BPD发生率也有逐年上升的趋势,BPD可导致慢性心肺及神经系统后遗症,严重影响早产儿的存活率及远期生存质量,成为NICU最为棘手的问题之一。近年来越来越多的文献报道解脲脲原体(Ureaplasma urealyticum, UU)的感染与BPD的发生发展有关,本文就支气管肺发育不良与解脲脲原体的关系的研究进展进行综述。
Abstract: Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in preterm infants charac-terized by alveolar simplicity, pulmonary microvascular dysplasia, and pulmonary interstitial fi-brosis, atelectasis, and cystic transformation. As the survival rate of preterm infants increases, the risk of cardiac arrest increases. The incidence of BPD also has an increasing trend year by year. BPD can lead to chronic cardiopulmonary and nervous system sequelae, seriously affecting the survival rate and long-term quality of life of premature infants, and becoming one of the most intractable problems in NICU. In recent years, more and more literatures have reported that Ureaplasma urea-lyticum (UU) infection is related to the occurrence and development of BPD. In summary, this paper reviews the research progress on the relationship between bronchopulmonary dysplasia and Urea-lyticum.
文章引用:赵文豪, 李芳. 支气管肺发育不良与解脲脲原体的关系的研究进展[J]. 临床医学进展, 2024, 14(1): 160-167. https://doi.org/10.12677/ACM.2024.141024

参考文献

[1] Northway JR., W.H., Rosan, R.C. and Porter, D.Y. (1967) Pulmonary Disease following Respirator Therapy of Hya-line-Membrane Disease—Bronchopulmonary Dysplasia. The New England Journal of Medicine, 276, 357-368. [Google Scholar] [CrossRef
[2] Thébaud, B., Goss, K.N., Laughon, M., et al. (2019) Bron-chopulmonary Dysplasia. Nature Reviews Disease Primers, 5, Article No. 78. [Google Scholar] [CrossRef] [PubMed]
[3] Abman, S.H., Bancalari, E. and Jobe, A. (2017) The Evolution of Bronchopulmonary Dysplasia after 50 Years. American Journal of Respiratory & Critical Care Medicine, 195, 421-424. [Google Scholar] [CrossRef
[4] Silwedel, C.S., Glaser, C.P. and Glaser, K. (2017) Ureaplas-ma-Associated Prenatal, Perinatal, and Neonatal Morbidities. Expert Review of Clinical Immunology, 13, 1073-1087. [Google Scholar] [CrossRef
[5] Kallapur, S.G., Kramer, B.W. and Jobe, A.H. (2013) Ureaplasma and BPD. Seminars in Perinatology, 37, 94-101. [Google Scholar] [CrossRef] [PubMed]
[6] Xu, Y.P., Hu, J.M., Huang, Y.Q. and Shi, L.P. (2022) Mater-nal Ureaplasma Exposure during Pregnancy and the Risk of Preterm Birth and BPD: A Meta-Analysis. Archives of Gy-necology and Obstetrics, 306, 1863-1872. [Google Scholar] [CrossRef] [PubMed]
[7] Viscardi, R.M. and Kallapur, S.G. (2015) Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update. Clinics in Perinatology, 42, 719-738. [Google Scholar] [CrossRef] [PubMed]
[8] Lowe, J., Watkins, W.J., Edwards, M.O., et al. (2014) Association between Pulmonary Ureaplasma Colonization and Bronchopulmonary Dysplasia in Preterm Infants: Updated Systematic Review and Meta-Analysis. Pediatric Infectious Disease Journal, 33, 697-702. [Google Scholar] [CrossRef
[9] Peretz, A., Tameri, O., Azrad, M., et al. (2020) Mycoplasma and Ureaplasma Carriage in Pregnant Women: The Prevalence of Transmission from Mother to Newborn. BMC Preg-nancy and Childbirth, 20, Article No. 456. [Google Scholar] [CrossRef] [PubMed]
[10] Zheng, X.D., Dan, L.I., Yang, D.H., et al. (2014) Association of Ureaplasma urealyticum Colonization with Development of Bronchopulmonary Dysplasia: A Systemic Review and Meta-Analysis. Journal of Huazhong University of Science and Technology-Medical Science, 34, 265-269.
[11] Schelonka, R.L., Katz, B., Waites, K.B., et al. (2005) Critical Appraisal of the Role of Ureaplasma in the Development of Bronchopulmonary Dysplasia with Metaanalytic Techniques. The Pediatric Infectious Disease Journal, 24, 1033-1039. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, E.E.L., Ohlsson, A. and Kellner, J.D. (1995) Association of Ureaplasma urealyticum Colonization with Chronic Lung Disease of Prematurity: Results of a Meta-Analysis. Journal of Pediatrics, 127, 640-644. [Google Scholar] [CrossRef
[13] Viscardi, R.M. (2010) Ureaplasma Species: Role in Diseases of Prematurity. Clinics in Perinatology, 37, 393-409. [Google Scholar] [CrossRef] [PubMed]
[14] Heggie, A.D., Bar-Shain, D., Boxerbaum, B., et al. (2001) Identifi-cation and Quantification of Ureaplasmas Colonizing the Respiratory Tract and Assessment of Their Role in the Devel-opment of Chronic Lung Disease in Preterm Infants. Pediatric Infectious Disease Journal, 20, 854-859. [Google Scholar] [CrossRef] [PubMed]
[15] Waites, K.B., Katz, B. and Schelonka, R.L. (2005) My-coplasmas and Ureaplasmas as Neonatal Pathogens. Clinical Microbiology Reviews, 18, 757-789. [Google Scholar] [CrossRef
[16] Li, Y.H., Brauner, A., Jonsson, B., et al. (2000) Ureaplas-ma urealyticum-Induced Production of Proinflammatory Cytokines by Macrophages. Pediatric Research, 48, 114-119. [Google Scholar] [CrossRef] [PubMed]
[17] Li, Y.H., Chen, M., Brauner, A., et al. (2002) Ureaplasma urealyticum Induces Apoptosis in Human Lung Epithelial Cells and Macrophages. Biology of the Neonate, 82, 166-173. [Google Scholar] [CrossRef] [PubMed]
[18] Okogbule-Wonodi, A.C., Chesko, K.L., Famuyide, M.E., et al. (2011) Surfactant Protein-A Enhances Ureaplasmacidal Activity in vitro. Innate Immunity, 17, 145-151. [Google Scholar] [CrossRef] [PubMed]
[19] Venturelli, N., Zeis, A., Beritto, T.D. and Hageman, J.R. (2021) Ureasplasmaand Its Role in Adverse Perinatal Outcomes: A Review. NeoReviews, 22, e574-e584. [Google Scholar] [CrossRef] [PubMed]
[20] Glaser, K. and Speer, C.P. (2015) Neonatal CNS Infection and Inflam-mation Caused by Ureaplasma Species: Rare or Relevant? Expert Review of Anti-Infective Therapy, 13, 233-248. [Google Scholar] [CrossRef] [PubMed]
[21] Spergser, J., Berger, A., Herkner, K.R., et al. (2013) In Utero Exposure to Ureaplasma spp. Is Associated with Increased Rate of Bronchopulmonary Dysplasia and Intraventricular Hemorrhage in Preterm Infants. Journal of Perinatal Medicine, 39, 331-336.
[22] Clifford, V., Tebruegge, M., Everest, N., et al. (2010) Ureaplasma: Pathogen or Passenger in Neonatal Meningitis? Pediatric Infectious Disease Journal, 29, 60-64. [Google Scholar] [CrossRef
[23] Polglase, G.R., Dalton, R.G.B., Nitsos, I., et al. (2010) Pulmonary Vascular and Alveolar Development in Preterm Lambs Chronically Colonized with Ureaplasma parvum. American Journal of Physiology-Lung Cellular and Molecular Physiology, 299, L232-L241. [Google Scholar] [CrossRef] [PubMed]
[24] Moss, T.J., Knox, C.L., Kallapur, S.G., et al. (2008) Experimental Amniotic Fluid Infection in Sheep: Effects of Ureaplasma parvum Serovars 3 and 6 on Preterm or Term Fetal Sheep. American Journal of Obstetrics and Gynecology, 198, 122.e1-122.e8. [Google Scholar] [CrossRef] [PubMed]
[25] Collins, J.J.P. (2010) Inflammation in Fetal Sheep from In-tra-Amniotic Injection of Ureaplasma parvum. American Journal of Physiology-Lung Cellular and Molecular Physiolo-gy, 299, L852-L860. [Google Scholar] [CrossRef] [PubMed]
[26] Normann, E., Lacaze-Masmonteil, T., Eaton, F., et al. (2009) A Novel Mouse Model of Ureaplasma-Induced Perinatal Inflammation: Effects on Lung and Brain Injury. Pediatric Re-search, 65, 430-436. [Google Scholar] [CrossRef
[27] Novy, M.J., Duffy, L., Axthelm, M.K., et al. (2009) Ureaplasma parvum or Mycoplasma hominis as Sole Pathogens Cause Chorioamnionitis, Preterm Delivery, and Fetal Pneumonia in Rhesus Macaques. Reproductive Sciences, 16, 56-70. [Google Scholar] [CrossRef] [PubMed]
[28] Yoder, B.A., Coalson, J.J., Winter, V.T., et al. (2003) Effects of Antenatal Colonization with Ureaplasma urealyticum on Pulmonary Disease in the Immature Baboon. Pediatric Re-search, 54, 797-807. [Google Scholar] [CrossRef
[29] Kramer, B.W., Albertine, K.H., Moss, T.J.M., et al. (2010) All-Trans Retinoic Acid and Intra-Amniotic Endotoxin-Mediated Effects on Fetal Sheep Lung. Anatomical Rec-ord, 291, 1271-1277. [Google Scholar] [CrossRef] [PubMed]
[30] Viscardi, R.M., Atamas, S.P., Luzina, I.G., et al. (2006) Antenatal Ureaplasma urealyticum Respiratory Tract Infection Stimulates Proinflammatory, Profibrotic Responses in the Preterm Baboon Lung. Pediatric Research, 60, 141-146. [Google Scholar] [CrossRef] [PubMed]
[31] Walsh, W.F., Butler, J., Coalson, J., et al. (1993) A Primate Model of Ureaplasma urealyticum Infection in the Premature Infant with Hyaline Membrane Disease. Clinical Infectious Diseases, 17, S158-S162. [Google Scholar] [CrossRef
[32] Kallapur, S.G., Willet, K.E., Jobe, A.H., et al. (2001) Intra-Amniotic Endotoxin: Chorioamnionitis Precedes Lung Maturation in Preterm Lambs. American Journal of Physi-ology-Lung Cellular and Molecular Physiology, 280, 527-536. [Google Scholar] [CrossRef
[33] Moss, T.J.M., Nitsos, I., Knox, C.L., et al. (2009) Ureaplasma Colonization of Amniotic Fluid and Efficacy of Antenatal Corticosteroids for Preterm Lung Maturation in Sheep. American Journal of Obstetrics and Gynecology, 200, 96.E1-96.E6. [Google Scholar] [CrossRef] [PubMed]
[34] Kramer, B.W., Joshi, S.N., Moss, T.J.M., et al. (2007) Endotox-in-Induced Maturation of Monocytes in Preterm Fetal Sheep Lung. American Journal of Physiology-Lung Cellular and Molecular Physiology, 293, L345-L353. [Google Scholar] [CrossRef] [PubMed]
[35] Kallapur, S.G., Nitsos, I., Moss, T.J.M., et al. (2005) Chronic Endotoxin Exposure Does Not Cause Sustained Structural Abnormalities in the Fetal Sheep Lungs. American Journal of Physiology-Lung Cellular and Molecular Physiology, 288, L966-L974. [Google Scholar] [CrossRef] [PubMed]
[36] Jobe, A.H. (2016) Mechanisms of Lung Injury and Bronchopul-monary Dysplasia. American Journal of Perinatology, 33, 1076-1078. [Google Scholar] [CrossRef] [PubMed]
[37] Silwedel, C., Fehrholz, M., Speer, C.P., et al. (2019) Differential Modulation of Pulmonary Caspases: Is This the Key to Ureaplasma-Driven Chronic Inflammation? PLOS ONE, 14, e0216569. [Google Scholar] [CrossRef] [PubMed]
[38] Viscardi, R.M. (2014) Ureaplasma Species: Role in Neonatal Morbidities and Outcomes. ADC Fetal & Neonatal Edition, 99, F87-F92. [Google Scholar] [CrossRef] [PubMed]
[39] Cassell, G.H., Waites, K.B., Crouse, D.T., et al. (1988) Association of Ureaplasma urealyticum Infection of the Lower Respiratory Tract with Chronic Lung Disease and Death in Very-Low-Birth-Weight Infants. The Lancet, 2, 240-245. [Google Scholar] [CrossRef
[40] 张林夕, 段翌, 高奥会, 等. 组织学绒毛膜羊膜炎与胎龄 < 34周早产儿支气管肺发育不良的相关性分析[J]. 中华新生儿科杂志, 2020, 35(3): 186-190.
[41] 吴永芳, 韩俊彦, 蒋思远, 等. 呼吸道解脲脲原体定植与早产儿支气管肺发育不良回顾性队列研究[J]. 中国循证儿科杂志, 2020, 15(6): 426-430.
[42] Baier, R.J., Loggins, J. and Kruger, T.E. (2003) Failure of Erythromycin to Eliminate Air-way Colonization with Ureaplasma urealyticum in Very Low Birth Weight Infants. BMC Pediatrics, 3, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[43] Turner, M.A., Jacqz-Aigrain, E. and Kotecha, S. (2012) Azithromycin, Ureaplasma and Chronic Lung Disease of Prematurity: A Case Study for Neonatal Drug Development. Archives of Disease in Childhood, 97, 573-577. [Google Scholar] [CrossRef] [PubMed]
[44] Karabay, O., Topcuoglu, A., Kocoglu, E., et al. (2006) Prevalence and Antibiotic Susceptibility of Genital Mycoplasma hominis and Ureaplasma urealyticum in a University Hospital in Turkey. Clinical and Experimental Obstetrics & Gynecology, 33, 36-38.
[45] Weisman, L.E., Leeming, A.H. and Kong, L. (2012) Appropriate Antibiotic Therapy Improves Ureaplasma Sepsis Outcome in the Neonatal Mouse. Pediatric Re-search, 72, 502-506. [Google Scholar] [CrossRef] [PubMed]
[46] Walls, S.A., Kong, L., Leeming, H.A., et al. (2009) Antibiotic Prophylaxis Improves Ureaplasma-Associated Lung Disease in Suckling Mice. Pediatric Research, 66, 197-202. [Google Scholar] [CrossRef
[47] Grigsby, P.L., Novy, M.J., Sadowsky, D.W., et al. (2012) Maternal Azithromycin Therapy for Ureaplasma Intraamniotic Infection Delays Preterm Delivery and Reduces Fetal Lung Injury in a Primate Model. American Journal of Obstetrics & Gynecology, 207, 475.E1-475.E14. [Google Scholar] [CrossRef] [PubMed]
[48] Krausse, R. and Schubert, S. (2010) In-Vitro Activities of Tetracy-clines, Macrolides, Fluoroquinolones and Clindamycin against Mycoplasma hominis and Ureaplasma ssp. Isolated in Germany over 20 Years. Clinical Microbiology and Infection, 16, 1649-1655. [Google Scholar] [CrossRef] [PubMed]
[49] Dong, Z.Q. (2005) Efficacy of Azithromycin in the Treat-ment of Chlamydia Trichomatis Conjunctivitis in Neofant. Chinese Journal of Antibiotics, 30, 428-429.
[50] Ballard, H.O., Anstead, M.I. and Shook, L.A. (2007) Azithromycin in the Extremely Low Birth Weight Infant for the Prevention of Bronchopulmonary Dysplasia: A Pilot Study. Respiratory Research, 8, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[51] Horner, P., Donders, G., Cusini, M., et al. (2018) Should We Be Testing for Urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in Men and Wom-en?—A Position Statement from the European STI Guidelines Editorial Board. Journal of the European Academy of Dermatology and Venereology, 32, 1845-1851. [Google Scholar] [CrossRef] [PubMed]
[52] Aaltone, R., Jalava, J., Laurikainen, E., et al. (2002) Cervical Ureaplasma Urealyticum Colonization: Comparison of PCR and Culture for Its Detection and Association with Preterm Birth. Scan-dinavian Journal of Infectious Diseases, 34, 35-40. [Google Scholar] [CrossRef] [PubMed]
[53] Frølund, M., Björnelius, E., Lidbrink, P., et al. (2014) Comparison between Culture and a Multiplex Quantitative Real-Time Polymer-ase Chain Reaction Assay Detecting Ureaplasma urealyticum and U. parvum. PLOS ONE, 9, e102743. [Google Scholar] [CrossRef] [PubMed]
[54] Colaizy, T.T., Morris, C.D., Lapidus, J., Sklar, R.S. and Pillers, D.A.M. (2007) Detection of Ureaplasma DNA in Endotracheal Samples Is Associated with Bronchopulmonary Dyspla-sia after Adjustment for Multiple Risk Factors. Pediatric Research, 61, 578-583. [Google Scholar] [CrossRef] [PubMed]